CHIPTS Director Steve Shoptaw Awarded the UCLA Public Impact Research Award

CHIPTS Center Director Steve Shoptaw, PhD, was recently awarded a UCLA 2024 Public Impact Research Award alongside five other outstanding awardees. Bestowed by the UCLA Office of Research and Creative Activities, this award celebrates the efforts of current faculty translating research into positive public action that benefits local, national, and global communities. Dr. Shoptaw’s award recognizes his longstanding efforts to support people impacted by stimulant use and HIV.

Dr. Shoptaw is a licensed psychologist, Professor in Family Medicine and Psychiatry and Biobehavioral Sciences, and Vice Chair for Research in Family Medicine at UCLA. In addition to his leadership of CHIPTS, he is Director of the UCLA Center for Behavioral and Addiction Medicine (CBAM) and of the UCLA Vine Street Clinic. He is a world-renowned expert on addiction treatment who brings his cutting-edge research straight to those who need it most at the UCLA Vine Street Clinic in Hollywood. His mission at Vine Street is to leverage scientific resources to address high rates of methamphetamine use, HIV infections, and overdose deaths among underserved individuals living in the surrounding area and across Los Angeles.

Dr. Shoptaw’s commitment to Angelenos is further exemplified by his nearly two decades of service as volunteer executive director for Safe House, a facility that provided permanent and emergency housing for those living with HIV/AIDS, substance use, and mental health disorders from 1996 to 2013. He now uses a mobile clinic to bring integrated health care services focused on addiction medicine and infectious diseases to those who are unstably housed, face transportation issues, and encounter other barriers to accessing care.

Dr. Shoptaw’s “Case-based Learning Collaborative on Stimulants” series stands out as another notable achievement. The Collaborative is a nationally recognized forum led by his addiction medicine fellows that educates doctors, nurses, social workers, and community stakeholders on best practices in implementing evidence-based addiction medicine approaches.

One of his most transformative research contributions has been his foundational work with contingency management for those who use cocaine or methamphetamine. Dr. Shoptaw advises Los Angeles County stakeholders, clinicians, and community-based organizations on how to implement this therapy — which positively reinforces desired behaviors – to help people reach their substance use-related goals.

Learn more about the Awards and other 2024 awardees on the Public Impact Research (PIR) Awards webpage.

CDC Announces Availability of $7 Million to Accelerate PrEP Uptake in EHE Jurisdictions

This content originally appeared on HIV.Gov. View the full article here.

Summary: New CDC funding will support efforts in EHE jurisdictions to increase PrEP access and uptake among priority populations disproportionately affected by HIV and low PrEP prescriptions.

The Centers for Disease Control and Prevention (CDC) recently issued a new competitive supplemental funding opportunity to increase PrEP access and uptake among priority populations and eliminate structural and social barriers that prevent equitable access to PrEP within EHE jurisdictions. The new funding opportunity is open to the health departments currently receiving funding for the Ending the HIV Epidemic in the U.S. (EHE) initiative through PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments. This supplemental program aims to accelerate progress toward meeting the National HIV/AIDS Strategy (2022-2025) and EHE goal of 50% PrEP coverage by the end of 2025.

CDC expects to award approximately $7 million to up to four health departments to support efforts to accelerate PrEP uptake focused on priority populations disproportionately affected by HIV and low PrEP prescriptions (i.e., Black and Latino gay, bisexual, and other men who have sex with men, and Black cisgender and transgender women) through patient navigation/case management services and improved access to and utilization of existing PrEP services not covered by other financial resources.

In addition to increasing PrEP access and uptake, these programs will incorporate elements to increase HIV non-occupational post-exposure prophylaxis (PEP) and STI doxycycline post-exposure prophylaxis (doxy PEP) awareness and access, including activities with clinicians, non-clinical community-based organizations, and persons at risk for HIV acquisition.

Applications are due by August 31, 2024.

White House Seeking Community Input on 2026-2030 National HIV/AIDS Strategy

This content originally appeared on HIV.Gov. View the full article here.

Summary: The White House and HHS are seeking public input on the development of the next National HIV/AIDS Strategy and national strategic plans for STIs, viral hepatitis, and vaccines. Participants at the National Ryan White Conference are encouraged to share their ideas on August 20. Other opportunities for input to follow.

The White House Office of National AIDS Policy (ONAP) and HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) have initiated the process to develop the next National HIV/AIDS Strategy (NHAS), which will cover 2026-2030. Concurrently, OIDP will be developing the next iterations of the STI National Strategic Plan, Viral Hepatitis National Strategic Plan, and Vaccines National Strategic Plan. The current NHAS spans 2022-2025 and the three national strategic plans also continue through 2025.

While federal, state, and community partners continue to implement those plans, ONAP and OIDP are beginning the processes to thoughtfully develop the next iterations of these plans by gathering public input. The first of several opportunities for community members to share their ideas will be on Tuesday, August 20, 2024, at the National Ryan White Conference in Washington, DC. A listening session will be held from 9:00 AM to 10:00 AM at the conference hotel. Conference participants are encouraged to join this session and share their ideas, recommendations, and feedback.

Additional listening sessions are planned, including at the upcoming U.S. Conference on HIV/AIDS in New Orleans. Written suggestions will also be sought through a Request for Information that will be published in the Federal Register soon.

Members of the California Statewide HIV and Aging Educational Initiative team at the Statewide Skill-BuIlding Symposium

Statewide Skill-Building Symposium: Addressing Mental Health among Older Adults with HIV Recap

In honor of HIV Long-Term Survivors Awareness Day, the California Statewide HIV and Aging Educational Initiative in partnership with Santa Clara County Getting to Zero hosted the Statewide Skill-Building Symposium: Addressing Mental Health among Older Adults with HIV on Wednesday, June 5, 2024, from 8:30 AM-4:30 PM PT at the Orchard City Banquet Hall in Campbell, CA. This one-day, in-person symposium aimed to help equip California service providers and frontline staff to better address the mental health needs of older adults with HIV, including the unique needs of long-term survivors.

During the symposium, leading experts offered engaging, interactive presentations on the intersection of mental health and loneliness & isolation, physical & cognitive decline, substance use, and other key issues impacting older adults with HIV. View the agenda with recorded presentations linked for each presentation below. You can also view the complete set of recorded presentations in our Statewide Skill-Building Symposium YouTube Playlist.

8:30-9:00 AM Check-In and Continental Breakfast
9:00-9:15 AM Welcome and Opening Remarks

California Statewide HIV and Aging Educational Initiative and Santa Clara County Getting to Zero

9:15-9:25 AM Update from the Office of AIDS: HIV, Aging, and Mental Health

Philip Peters, MD, Medical Officer, Office of AIDS, California Department of Public Health

9:25-10:10 Keynote Address — Four A’s of Caring for Our Elder HIV Community: Ask, Acknowledge, Advocate, and Amplify

William Hua, PhD, Clinical Psychologist and Executive Director, Alliance Health Project, UCSF

10:10-10:20 AM Break
10:20-11:50 AM Take Action on Loneliness and Isolation

11:50 AM-12:50 PM Lunch
12:50-2:20 PM Take Action on Physical and Cognitive Decline

2:20-2:30 PM Break
2:30-4:00 PM Take Action on Taboo Topics: Sexual Health and Substance Use

4:00-4:20 PM Local Reflections and Call to Action

Harsha Ramchandani, MD, Chief Medical Officer, Bay Area Community Health (BACH)

4:20-4:30 PM Closing Remarks
California Statewide HIV and Aging Educational Initiative

The California Statewide HIV and Aging Educational Initiative is a collaborative capacity-building initiative led by CHIPTS, APLA Health, the Pacific AIDS Education and Training Center (PAETC)—LA and BANCC, and the San Francisco AIDS Foundation. If you have any questions, please contact Elena Rosenberg-Carlson at erosenberg-carlson@mednet.ucla.edu.

Zero HIV Stigma Day Redefines Narratives

This content originally appeared on HIV.Gov. View the full article here.

Summary: HIV.gov highlights why Zero HIV Stigma Day is relevant in 2024 and how this awareness day addresses stigma.

July 21st is the second annual Zero HIV Stigma Day, which helps raise awareness about HIV stigma and how to help stop it. This year’s theme, “Beyond Labels: Redefining HIV Narratives,” is a call to move beyond stereotypes associated with people with HIV and to celebrate the decades of advocacy that is changing those narratives. The day coincides with the birthday of Prudence Mabele, an activist who was the first woman in South Africa to disclose her HIV status in 1992.

Zero HIV Stigma Day is a joint initiative of NAZ and the International Association of Providers of AIDS Care (IAPAC)Exit Disclaimer in collaboration with the Global HIV Collaborative and Fast-Track Cities Institute. To highlight why this awareness day matters in 2024, HIV.gov spoke with Kalvin Pugh, Senior Advisor, Community Engagement, IAPAC.

Mr. Pugh said stigma doesn’t just impact those with HIV, but it also prevents individuals from accessing services for testing or prevention. He added that the global awareness day is making an impact on reducing stigma.

“Since this is the second commemoration, the noticeable differences that I saw were on a community level and on a personal level with folks who I interacted with last year, those who felt that the Human First film was really touching for them and elevated the different aspects of stigma that people interact with daily.”

Mr. Pugh said one of the most notable outcomes of the awareness day is that a young woman in the UK who has had HIV for a long time finally felt comfortable enough to disclose her status on social media and share that she was doing just fine.

“I think the further we go, the more we elevate these messages, the better, and the more outcomes we hope to improve,” he said, adding that stigma may never be eliminated, but we can all do our part. “What we really need to do if we’re going to save the planet and move humanity forward is show kindness and compassion.”

HIV-related stigma is addressed in the National HIV/AIDS Strategy, which calls on all sectors of society to work together to combat stigma and discrimination to reduce new transmissions and improve health outcomes for people with HIV.

CHIPTS at AIDS 2024

The 25th International AIDS Conference (AIDS 2024), will take place in Munich, Germany, from July 22-26, 2024. Pre-conferences will be held on July 20-22, 2024. Learn more about AIDS 2024 and the exciting work of our CHIPTS scientists featured at the conference below.

What is AIDS 2024?

The International AIDS Conference is the world’s largest conference on HIV and AIDS. As a global platform to advance the HIV response, it sits uniquely at the intersection of science, advocacy, and human rights. The 25th International AIDS Conference, AIDS 2024, will convene thousands of people living with, affected by, and working on HIV to share knowledge, best practices, and lessons learned from the HIV response over the past 40 years.

The theme for AIDS 2024, “Put people first,” reflects the organizers’ acknowledgment of the HIV pandemic as a significant threat to public health and individual well-being. This principle of prioritizing people is essential in guiding efforts aimed at ending the HIV pandemic.

CHIPTS at AIDS 2024

Several CHIPTS scientists will be sharing exciting research findings and project updates at AIDS 2024, contributing to the dissemination of crucial information that advances HIV prevention and treatment initiatives globally. We are delighted to highlight satellite sessions, oral session abstracts, and poster session abstracts featuring the important work of our CHIPTS scientists.

Monday, July 22, 2024

Satellite Session

SAT015 – HIV-related intersectional stigma reduction and discrimination intervention findings from NIH Promoting Reductions in Intersectional StigMa (PRISM) clinical trials

  • Session Start: 9:30 AM (Room 5/Channel 8)
  • Presentation Title: A CBT-group intervention to increase HIV testing and PrEP use among Latino sexual minority men (R01MH121256; NCT04225832) (Laura Bogart)
Tuesday, July 23, 2024

Oral Abstract Session

OAE04 – Advanced HIV disease: Hiding in plain sight

  • Session Start: 3:00 PM (Room 14b/Channel 3)
  • Presentation Title: Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study (Raphael Landovitz)

Poster Session

Poster Abstract – TUPEC186

  • Session Start: 12:00 PM
  • Poster Title: Technology-based Interventions, with a stepped care approach, for reducing sexual risk behaviors and increasing PrEP initiation among Transgender and Gender Expansive Youth and Young Adults (ATN 160)
  • Authors: K.J. Horvath, D. Cain, J.A. Rusow, D. Benkeser, L. Schader, B.A. Gwiazdowski, S.J. Skeen, M. Hannah, M. Belzer, M. Castillo, K.H. Mayer, M.E. Paul, J. Hill-Rorie, N. Dorcey-Johnson, J. McAvoy-Banerjea, T. Sanchez, P.S. Sullivan, L. Hightow-Weidman, C.J. Reback
Wednesday, July 24, 2024

Satellite Session

SAT074 – Latching onto freedom: A global dialogue on reproductive justice for women living with HIV

  • Session Start: 7:00 AM (Room 14a/Channel 9)
  • Presentation Title: Dignified breastfeeding for women living with HIV through the U=U framework (Dvora Davey)

Poster Sessions

Poster Abstract – WEPEB101

  • Session Start: 12:00 PM
  • Poster Title: Prediction of intracellular tenofovir-diphosphate concentrations during pregnancy using a semi-mechanism-based population pharmacokinetic model
  • Authors: Yu, R. Bies, J. Momper, B. Best, M. Mirochnick, R. Heffron, C. Celum, K. Brooks, P. Anderson, M. Marzinke, D. Joseph Davey, L. Myer, G. Doncel, C. Hendrix, R. Scott

Poster Abstract – WEPEC206

  • Session Start: 12:00 PM
  • Poster Title: “Everyone should have access to it”: perspectives on PrEP product choice and implementation from MSM and TGW in an injectable PrEP trial
  • Authors: Psaros, R.J. Landovitz, E.M. Waldron, W. Rice, C.F. Kelley, T. Oyedele, L. Coehlo, N. Phanuphak, Y. Singh, K. Middelkoop, S. Griffith, M. McCauley, A.M. Rivas, O.Y. Chen, T. Jupimai, N. Lawrence, G. Goodman, J. Rooney, A. Rinehart, J. Clark, V. Go, J. Sugarman, S. Fields, A. Adeyeye, B. Grinsztejn, S.A. Safren

Poster Abstract – WEPEE545

  • Session Start: 12:00 PM
  • Poster Title: Telemedicine to improve health equity in two federally qualified health centers in Los Angeles: is telephone the answer?
  • Authors: Walker, C. Moucheraud, D. Butler, J. de Vente, K. Tangonan, C. Takayama, T. Horn, S. Shoptaw, J.S. Currier, J. Gladstein, R. Hoffman

Poster Abstract – WEPEC307

  • Session Start: 12:00 PM
  • Poster Title: Effect of high-risk mobility on treatment interruption among men in Malawi: secondary analysis of two randomized controlled trials
  • Authors: Thorp, K. Balakasi, M. Ramesh, I. Robson, A. Choko, R. Hoffman, S. Shoptaw, K. Dovel

Poster Abstract – WEPEC302

  • Session Start: 12:00 PM
  • Poster Title: Acceptability of long-acting injectable antiretroviral treatment (LAI-ART) among young Black sexual minority men (SMM) living with HIV in the Southern United States
  • Authors: Ogunbajo, W. Vincent, D. Siconolfi, C. Campbell, L. Pollack, S. Kegeles, G. Rebchook, S. Tebbetts, E. Storholm

Poster Abstract – WEPED343

  • Session Start: 12:00 PM
  • Poster Title: Implementation of a hybrid online-offline intervention to address HIV stigma and gender disparity for women living with HIV in Vietnam
  • Authors: C. Lin, B.D. Nguyen, H. Dang, T.T. Nguyen, L. Li, M.G. Le
Thursday, July 25, 2024

Poster Sessions

Poster Abstract – THPEE516

  • Session Start: 12:00 PM
  • Poster Title: FastPrEP: evaluating factors associated with PrEP initiation from community-based mobile clinics compared to fixed-site primary health facilities in adolescents and young people in Cape Town, South Africa
  • Authors: Rousseau, K. Lebelo, N. Mathola, P. Macdonald, O. Vanto, P. Fuzile, P. Smith, T. Wonxie, L. Fynn, M. Wallace, D. Davey, L.-G. Bekker

Poster Abstract – THPEC176

  • Session Start: 12:00 PM
  • Poster Title: Impact of changing PrEP regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023)
  • Authors: Q.L. Pham, N. Setrakian, H.T. Bui, P. Adamson, T.N. Hoang, L.M. Giang, P.M. Gorbach

Poster Abstract – THPEA029

  • Session Start: 12:00 PM
  • Poster Title: A first-in-human phase 1 trial of PGT121.414.LS administered alone and in combination with VRC07-523LS: safety, tolerability, pharmacokinetics, and neutralization activity (HVTN 136/HPTN 092)
  • Authors: Edupuganti, C. Hurt, K. Stephenson, Y. Huang, C. Paez, C. Yu, C. Yen, B. Hanscom, Z. He, M. Miner, T. Gamble, J. Heptinstall, K.E. Seaton, A. Eaton, S. Regenold, W. Chege, M. Anderson, N. McCloskey, L. Zhang, E. Piwowar-Manning, M.E. Ackerman, M. Pensiero, B. Dye, R.J. Landovitz, K.H. Mayer, M. Siegel, M. Sobieszczyk, S.R. Walsh, L. Gama, D.H. Barouch, D. Montefiori, G. Tomaras, HVTN136/HPTN 092 study team

Poster Abstract – THPEC292

  • Session Start: 12:00 PM
  • Poster Title: Increasing COVID-19 vaccine coverage among art clients through a comprehensive vaccination intervention in Kasungu district, Malawi
  • Authors: Chivwara, C. Saini, R. Khunga, E. Makwakwa, H. Kanise, J. Njala, D. Smith, S. Phiri, C. Moucheraud, E. Chikuse, R. Hoffman, J. van Oosterhout

Poster Abstract – THPED380

  • Session Start: 12:00 PM
  • Poster Title: HPTN 094: engaging key community stakeholders in preparation for mobile clinics providing integrated health services (medication for opioid use disorder and HIV treatment/prevention services) for people who inject drugs (PWID)
  • Authors: Albano, J. Harris, C. Blades, A. Davis, J. Lucas, S. Alvarado, J. Yeager, S. Edwards, P. Andrew, N. El-Bassel, S. Shoptaw

Poster Abstract – THPED326

  • Session Start: 12:00 PM
  • Poster Title: Health or income? How men living with HIV in Malawi experience and navigate decisions between income generation and ART refills
  • Authors: Ramesh, K. Balakasi, J. Hubbard, M. Thorp, L. Kamtsendero, M. Sanena, S. Phiri, M. Cornell, T. Coates, K. Holland, A. Choko, K. Dovel

Poster Abstract – THPEC277

  • Session Start: 12:00 PM
  • Poster Title: Factors associated with repeat treatment interruption among men in Malawi: findings from two randomized control trials
  • Authors: K.T. Balakasi, M. Thorp, I. Robson, M. Mphande, C. Lemani, A. Choko, S. Phiri, R. Hoffman, T.J. Coates, K. Dovel

Poster Abstract – LB18

  • Session Start: 12:00 PM
  • Poster Title: Efficacy and safety of ensitrelvir in non-hospitalized adults at standard or high risk of progression to severe COVID-19: the SCORPIO-HR phase 3, randomized, double-blind, placebo-controlled trial
  • Authors: K. Chew, A. Luetkemeyer, S. Lacey, M. Hughes, L. Harrison, E. Daar, J. Eron, C. Fletcher, A. Greninger, D. Hessinger, J. Li, D. Mailhot, D. Wohl, M. Chayakulkeeree, P. Elistratova, O. Makinde, G. Morgan, S. Portsmouth, T. Uehara, D. Smith, J. Currier, on behalf of the SCORPIO-HR/ACTIV-2d (ACTG A5407) study team

Poster Abstract – LB32

  • Session Start: 12:00 PM
  • Poster Title: Understand how health, well-being, social support, violence, and stigma shape resilience pathways among Kenyan youth aged 15-24 living with HIV in urban informal settlements through structural equation modeling
  • Authors: Wang, H. Owoko, C. Kabiru, P. Gorbach, S. Muyingo
Friday, July 26, 2024

Oral Abstract Session

OAD37 – Exploring the kaleidoscope of experiences among people living with HIV

  • Session Start: 12:00 PM (Room 5/Channel 8)
  • Presentation Title: Primary outcomes of an intervention employing a hybrid online-offline approach to address HIV stigma among women living with HIV in Vietnam (Chunqing Lin)

Poster Sessions

E-Poster Abstract – EPB026

  • Session Start: 12:00 PM
  • Poster Title: Association of antiretroviral therapy with cognition and resting-state functional connectivity in people with HIV
  • Authors: Ibnidris, J. Ipser, T. M. Nir, L. Chang, R. A. Cohen, T. Ernst, K. J. Kallianpur, E. C. Porges, C. M. Shikuma, S. Thomopoulos, H. J. Zar, P. M. Thompson, S. Shoptaw, D. J. Stein, N. Jahanshad, ENIGMA HIV Working Group

E-Poster Abstract – EPE158

  • Session Start: 12:00 PM
  • Poster Title: Assessing preferences of long-acting PrEP modalities among oral PrEP-experienced postpartum individuals in Cape Town, South Africa: a qualitative study
  • Authors: Wara, L. Court, K. Moopelo, N. Mashele, C. Ntwasa, R. Mvududu, A. Miller, S. Schoetz Dean, C. Orrell, L. Knight, L. Myer, R. Hoffman, D. Joseph Davey

To learn more about AIDS 2024 and access the conference materials, visit: https://www.iasociety.org/conferences/aids2024

National HIV Testing Day 2024

June 27, 2024 – Today, CHIPTS joins partners across the U.S. in observing National HIV Testing Day (#HIVTestingDay), a day to highlight the importance of getting tested for HIV and linked to HIV prevention and treatment options.

This year’s theme is “level up your self-love: check your status,” emphasizing the need to honor and value your health by knowing your HIV status so you can choose options to stay healthy. With about 13% of people with HIV in the United States unaware of their HIV status, individuals need to feel empowered to get tested for HIV.

People who receive a negative test result can take advantage of tools such as pre-exposure prophylaxis (PrEP), condoms, and other sexual health services to prevent HIV and other sexually transmitted infections. People who receive a positive test result can start HIV treatment to manage their HIV infection and stay healthy. Talk to your healthcare provider, use the HIV Testing Sites & Care Services Locator, or explore self-testing to choose the HIV testing option that is right for you.

As an AIDS Research Center, CHIPTS is excited to share recent research from our Center scientists that can inform community and public health efforts to improve HIV testing and prevention strategies:

Factors associated with lifetime HIV testing among women in four Southeast Asian countries: Evidence from the demographic and health surveys

Point-of-Care Sexually Transmitted Infection Testing Improves HIV Preexposure Prophylaxis Initiation in Pregnant Women in Antenatal Care in Cape Town, South Africa, 2019 to 2021

Factors associated with HIV testing and treatment among young Black MSM and trans women in three jail systems

Characteristics of Received HIV Prevention Advocacy from Persons Living with HIV in Uganda, and Associations with HIV Testing and Condom Use Among Social Network Members

Statements by HHS Secretary Xavier Becerra and HHS Principals on Pride Month

This content originally appeared on HHS Press Office. View the full article here.

After raising the progress Pride Flag outside of the Department of Health and Human Services (HHS) headquarters, HHS Secretary Xavier Becerra and other HHS leaders from across the Department released the following statements to celebrate Pride Month:

Xavier Becerra – HHS Secretary

“Each year during Pride Month we celebrate the LGTBQI+ leaders, activists, and trailblazers, including those who have helped to improve the health of our nation over the past two centuries. We all are freer because of people like Marsha P. Johnson, Dr. Sara Josephine Baker, and Dr. John Ercel Fryer.

Across the Biden-Harris Administration, we have a new generation of changemakers – Admiral Levine, Secretary Buttigieg, White House Press Secretary Karine Jean-Pierre, and all of our LGBTQI+ staff – focused on shaping a more equitable and inclusive future.

HHS works every day to build an America where LGBTQI+ Americans have access to quality, affordable health care and can go to the doctor without fear of stigma or discrimination. Where the state you live in doesn’t determine whether you can access lifesaving, gender-affirming care. And where more communities embrace the diversity that has always strengthened our national character.

We have made tremendous progress but know there is much work still to be done. We will keep fighting for a future that doesn’t define being who you are as courageous.”

Andrea Palm – HHS Deputy Secretary

“HHS is doing the work to make sure the LGBTQI+ community has the same access to care and resources as all Americans, during Pride month, and all year long.

We work hard to advance key policies and programs that help make sure everyone feels safe and seen – at work, at school, and in their doctor’s office. We’ve affirmed civil rights and equal opportunity in HHS funded programs and services, engaged and listened to transgender youth and their families, and created specialized support for LGBTQI+ youth on the 988 Suicide & Crisis Lifeline.

We remain committed to elevating voices from the LGBTQI+ community and celebrating the LGBTQI+ leaders throughout history, across the country, and within our own HHS family who are opening new doors and creating healthier futures.”

Jeff Hild – Principal Deputy Assistant Secretary for Children and Families (ACF) and Acting Assistant Secretary for Children and Families

“ACF is proud to celebrate and support LGBTQI2S+ children, youth, parents, and families. We affirm this support by taking action, including through a strengthening regulation to ensure safe foster care placements for LGBTQI2S+ young people.  We say to LGBTQI2S+ children, the parents who love and support them, and LGBTQI2S+ parents and young adults: thank you for being you, we are with you, and we will continue to provide services and supports for you to be safe, healthy, and have every opportunity to thrive.”

Alison Barkoff – Senior official performing the duties of the Administration for Community Living Administrator and the Assistant Secretary for Aging (ACL)

“The LGBTQI+ community includes people of all ages, with and without disabilities. During Pride Month, the Administration for Community Living celebrates that diversity and reaffirms our commitment to ensuring that our programs respect the identities and culture of each person they serve, and that all older adults and disabled people are welcomed. Sexual orientation and gender identity should never be barriers to getting the services and supports a person needs to thrive in the community.”

Renee Wegrzyn, Ph.D. – Director, Advanced Research Projects Agency for Health (ARPA-H)

“Pride Month is a time to honor and celebrate the courage, resilience, and progress of LGBTQI+ individuals throughout history. It also serves as a reminder that we must continue to strive for a world where everyone—regardless of their sexual orientation, gender identity, or expression—can live freely and without fear of discrimination. At ARPA-H, we are creating a culture that promotes diversity, accessibility, and inclusion in all aspects of our work and driving innovation in health and technology to better serve and support all Americans, including the LGBTQI+ community. Let us celebrate Pride Month with open hearts and minds and a renewed dedication to building a world where love, acceptance, and cutting-edge advancements in health and technology prevail.”

Dawn O’Connell – Assistant Secretary for Preparedness and Response (ASPR)

“ASPR is committed to ensuring that inclusion and equity are woven throughout every aspect of our nation’s preparedness and response efforts. ASPR’s close partnership with the LGBTQI+ community reflect this commitment. Pride month is an opportunity to stand with our LGBTQI+ partners and reaffirm our dedication to supporting their needs in times of a public health emergency or disaster response.”

Mandy Cohen, M.D.– Director, Centers for Disease Control and Prevention (CDC)

“During Pride Month, we honor the contributions of the LGBTQI+ community to public health. CDC is dedicated to addressing health disparities affecting LGBTQI+ individuals to ensure access to vital health services for all. Fostering supportive and inclusive communities is critical to wellbeing, and the CDC remains committed to supporting the health of our diverse communities through data, expertise, and investments.”

Chiquita Brooks-LaSure – Administrator, Centers for Medicare and Medicaid Services (CMS)

“At CMS, high-quality health care for LGBTQI+ people is part of the vision now and for future generations. All who rely on coverage through Medicare, Medicaid and CHIP, and the Marketplaces deserve fair, comprehensive coverage, regardless of sexual orientation or gender expression. In recognition of Pride Month, we stand with the LGBTQI+ community and continue to partner to make health care a right for all.”

Robert M. Califf, M.D. – Commissioner, Food and Drug Administration (FDA)

“Pride Month is an opportunity for all of us to demonstrate how proud we are to stand with the LGBTQIA+ community, who are persevering through an ongoing struggle for equality and justice. Through the FDA lens, ensuring people from diverse populations, including the LGBTQIA+ community join clinical trials is key to advancing health equity. FDA-approved medical products must work for all populations as they are intended, and widening the lens of clinical research volunteers will provide essential information to meet this goal.”

Roselyn Tso – Director, Indian Health Service (IHS)

“Indian Country has a rich history of recognizing the unique value of each and every member of our communities. For time immemorial, our traditions have taught us to lift up the contributions that our Two Spirit and LGBTQI+ relatives bring to our nations every day. As director of the Indian Health Service, it is an honor to uphold these ways. IHS remains ever-committed to doing all we can to ensure Two Spirit and LGBTQI+ Indigenous people have access to the highest quality health care in safe, welcoming, and comfortable environments. Across the agency, we endeavor to build the policies, protocols, opportunities, and partnerships necessary to ensure that Two Spirit and LGBTQI+ Indigenous people are respected, protected, and provided with the care they deserve.”

Miriam E. Delphin-Rittmon, Ph.D. – Assistant Secretary for Mental Health and Substance Use (SAMHSA)

“Pride Month serves dual purposes: to celebrate LGBTQI+ joy in living open, authentic lives, and to commemorate historic and ongoing struggles that make doing so possible. A higher prevalence of substance use and mental health issues has been well documented among people who identify as LGBTQI+. SAMHSA is committed to eliminating health inequities experienced by the LGBTQI+ community through efforts such as the LGBTQI+ Family Support grant program, 988 LGBTQI+ specialized services for youth and young adults, and technical assistance and training through the Center of Excellence on LGBTQI+ Health Equity.”

Melanie Fontes Rainer – Director, HHS Office for Civil Rights (OCR)

“This Pride Month, I am reflecting on the stories I have heard from LGBTQI+ communities across the country: the parents who had to relocate – leaving their homes, friends, and lives – for their children’s safety and health, the parents who cannot afford to leave their communities and are subjected to harassment daily for loving their kids, our trans and nonbinary siblings who feel the stress and carry the burden perpetuated by hateful rhetoric and laws, and the advocates and communities nationwide who show up, stand up and fight for equality. This devasting reality is why I am proud to work in an Administration that is fighting this battle on all fronts—to protect health care. We are proud to celebrate the vibrancy and the strength of the LGBTQI+ community that reflects the fundamental values of America. We will continue to safeguard civil rights protections for every person regardless of who they are or who they love.”

Monica Bertagnolli, M.D. – Director, National Institutes of Health (NIH)

“This Pride Month, NIH is proud of the work being done across the agency to cultivate inclusion in clinical trials and other health research that is representative of sexual and gender diverse communities. This work is vital to advance the knowledge base in SGM health and optimize health outcomes for all LGBTQI+ Americans.”

Admiral Rachel Levine, M.D. – Assistant Secretary for Health (OASH)

“Pride reminds us that we are a strong, resilient, and powerful community that fights hate with love. As we celebrate Pride Month, we should recognize how far we have come, even as we take stock of the challenges that we face. Everything we do at HHS emphasizes health equity and this pride month, we are making a focused effort to address and eliminate the health disparities within the LGBTQI+ community. We are focused on our efforts to end the HIV epidemic in the US, prevent syphilis and congenital syphilis, and promote access to care for LGBTQI+ people across America. Together, we can work to support healthy people, healthy communities, and a healthy nation for all. I am a positive and optimistic person, and I believe that working together, we can create a healthier, better future for all people living in the United States.”

Vivek Murthy, M.D. – U.S. Surgeon General

“This Pride Month, I want everyone to know they are seen, they are valued, and they belong. Every day, I am inspired by the strength and courage LGBTQI+ youth demonstrate across the country – and I proudly stand by them in their quest to end discrimination.”

Samuel R. Bagenstos – HHS General Counsel (OGC)

“This year’s Pride Month offers us the opportunity to reflect on just how much the LGBTQI+ movement has achieved, and on the continuing threats to equal treatment and full inclusion of LGBTQI+ individuals in our community. The Office of the General Counsel is proud to support the Department’s efforts to defend and advance the civil rights of LGBTQI+ people at this important point in our history.”

Loyce Pace – Assistant Secretary for Global Affairs (OGA)

“As we celebrate Pride Month, we honor the strength, resilience, and contributions of the LGBTQ+ community worldwide. Ensuring that every individual, regardless of their sexual orientation or gender identity, has access to the health services they need and deserve is central to our work.

The Office of Global Affairs recognizes that health equity is a fundamental human right. Our commitment to fostering a world where everyone, including LGBTQ+ individuals, can thrive in good health is unwavering. This dedication is essential for sustainable development and global well-being.”

Robert Otto Valdez, Ph.D., M.H.S.A. – Director, Agency for Healthcare Research and Quality (AHRQ)

“During Pride Month, we recognize the contributions the LGBTQ+ community has made on all aspects of American life and reaffirm the right of all people to live with liberty and dignity. At AHRQ, we also renew our commitment to helping create safe and inclusive health care settings where LGBTQ+ patients receive high quality care that is person-centered, safe, timely, and effective.”

Carole Johnson – Administrator, Health Resources and Services Administration (HRSA)

“This Pride Month, HRSA continues to proudly stand with the LGBTQI+ community, ensuring access to quality health care and supportive services through HRSA’s Ryan White HIV/AIDS Program, HRSA-supported community health centers, and other programs. Together, we continue to advance health equity and promote the well-being of the LGBTQI+ community.”

Micky Tripathi, Ph.D. – National Coordinator for Health Information Technology (ONC)

“Accurate data collection is critical to more fully understanding and addressing the health inequities that persist in our nation’ communities – which includes the LGBTQI+ community. That’s why the Office of the National Coordinator for Health IT is continually advancing data standards, such as meaning, context, and expected use of sexual orientation and gender identity, to support users’ abilities to identify, assess, and analyze gaps in care, leading to better patient care, experiences and ultimately, health outcomes.”

Jeff Nesbit – Assistant Secretary for Public Affairs (ASPA)

“During Pride Month and throughout the year, let us thank the LGBTQI+ doctors, nurses, caregivers, researchers, and scientists who keep our communities healthy and strong. Here at HHS, we honor them through our work to expand access to care, stand up to discrimination, and connect people with critical health information.

Members of the LGBTQI+ community are some of the greatest authors of our long American story of progress. Today, we celebrate them and the historic advancements they’ve penned for our country’s health and wellbeing.”

Bertha Alisia Guerrero – Director, Office of Intergovernmental and External Affairs (IEA)

“Today and every day, we honor the resilience of the LGBTQI+ community. We celebrate the progress we have made together alongside our partners, while acknowledging the work that still lies ahead. At IEA, we stand in solidity with the LGBTQI+ community, families and allies, as we renew our shared commitment to dismantling barriers to health care, ensuring health equity and championing a future where every LGBTQI+ person is free to be who they are without fear.”

Melanie Egorin – Assistant Secretary for Legislation (ASL)

“During this Pride Month and every month, we continue to work with the Department divisions, Congress, and all our partners to ensure equitable, meaningful, and inclusive access to quality health care, life saving innovation, and important human services without fear of stigma or discrimination. We share the Biden-Harris Administration goal of reducing barriers to care for all Americans.”

Cheryl Campbell – Assistant Secretary for Administration (ASA)

“During Pride Month, we celebrate the vibrant and resilient LGBTQI+ community and reaffirm our commitment to Diversity, Equity, Inclusion, and Accessibility (DEIA) as cornerstones of our mission at HHS. Our work is driven by the belief that everyone deserves access to quality healthcare and the freedom to live their true, authentic lives without fear of discrimination. As Bayard Rustin once said, ‘We are all one. And if we don’t know it, we will learn it the hard way.’ Let us honor his legacy by ensuring that HHS—recognized as one of the Best Places to Work—is where justice, equality, and acceptance prevail, demonstrating through our actions that love and fairness are the norms.

By embracing diversity and fostering an inclusive environment, we are not just supporting individuals—we are strengthening the very fabric of our society. Let us continue to stand together, championing equality and justice and creating a future where every voice is heard, every person is valued, and everyone can thrive.

In Audre Lorde’s powerful words, ‘It is not our differences that divide us. It is our inability to recognize, accept, and celebrate those differences.’ At HHS, we are steadfast in our commitment to celebrating our differences and creating a culture where everyone feels valued and included.”

Rebecca Haffajee, Ph.D., Principal Deputy Assistant Secretary for Planning and Evaluation (ASPE)

“Pride Month is an opportunity to celebrate LGBTQI+ communities and appreciate the rich diversity of our nation. In ASPE, we highly value and prioritize inclusion and equity in our workforce and in the research and evaluations we pursue – ultimately aiming to improve the health and well-being of every person in our country, including LGBTQI+ individuals.”

SOGI Data Action Plan: One Year Impact Brief – PDF (PDF, 492KB)HHS released a brief about the Department’s efforts to incorporate LGBTQI+ populations in HHS surveys and data collection efforts one year after the launch of its Sexual Orientation and Gender Identity (SOGI) Data Action Plan approved by Secretary Xavier Becerra in June 2023. This is an important step in improv­ing understanding of this community, promoting data-based policymaking, and addressing health equity broadly. All divisions of HHS have reviewed their data instruments and initiated determinations and have started incorporating SOGI data measures where possible. Examples of data instruments that have incorporated or improved SOGI data measures in response to the plan include Affordable Care Act Marketplace and Medicare enrollment applications, CDC STI epidemiological surveys, and national substance use and mental health surveys.

CDC Fact Sheet on ACESs among LGBTQI+ Young People – PDF (PDF, 499KB)HHS also released a new CDC factsheet to highlight what we know about adverse childhood experiences (ACEs) among LGBTQI+ young people.  It defines ACEs, describes the burden of ACEs among people who identify as LGBTQI+, and shows the types of ACEs young people who identify as LGBTQI+ are more likely to experience than people who identify as heterosexual and whose gender matches sex at birth. This factsheet also outlines the science behind experiencing interpersonal discrimination, including discrimination due to sexual and gender identity, and how this experience is an ACE. The factsheet describes how ACEs can be prevented for all people, including those who identify as LBGTQI+ and includes links to several evidence-based CDC resources that can help prevent ACEs and promote positive childhood experiences.

To View HHS LGBTQI+ Fact Sheet, click here – PDF

EHE Jurisdictions Innovate to Expand HIV Testing Opportunities

This content originally appeared on HIV.Gov. View the full article here.

Partners across the 57 prioritized jurisdictions implementing the Ending the HIV Epidemic in the U.S. (EHE) initiative are taking many innovative approaches to activities under the initiative’s Diagnose pillar. These include providing HIV testing in a local jail system and bringing HIV and other syndemic-related services to communities via a mobile clinic. As the initiative’s fifth year continues, members of the HHS Office of Infectious Disease and HIV/AIDS Policy’s (OIDP) EHE and Engagement Teams have been hearing more about testing activities in several jurisdictions. Below are just a few of the innovative Diagnose pillar activities they have learned about that may be useful models for other jurisdictions to adapt.

Parkland Health Increases HIV Testing and Diagnoses in Dallas County’s Jail System

Parkland Health, a public hospital and clinic system and a partner in Dallas County’s (Texas) EHE plan, provides regular opt-out HIV testing for all individuals entering the Lew Sterrett Justice Center, Dallas County’s jail. This year, the jail is expected to conduct more than 12,000 tests. In addition, Parkland Health’s group sexual health classes and educational podcasts have contributed to increased HIV and STI testing during incarceration. In the jail, there have been 150 diagnoses per year for the past two years, a significant increase compared to the 60 per year in previous years. In addition to its work in the county jail, Parkland also facilitates swift linkage to HIV care for patients at the time of diagnosis regardless of how they enter the health system. A team of healthcare providers, case managers, peer navigators, financial counselors, and medication access specialists collaborates with patients to provide personalized care and ensure access to treatment and program retention. Currently, Parkland serves more than 6,300 people with HIV.

Mobile Clinic Brings HIV Testing, Other Services to Tribal Communities in San Diego County

The Southern Indian Health Council (SIHC), a recipient of an Ending the HIV/HCV/STI Epidemic in Indian Country cooperative agreement, is a Federally Qualified Health Center in southeastern San Diego County, California. SIHC serves a Tribal Consortium comprised of seven American Indian tribes. With EHE funds provided by the Indian Health Service, SIHC has launched a mobile health clinic called Room 2 Roam (R2R), which offers syndemic-related care to roughly 2,000 people living within the rural SIHC reservation lands. The services provided include rapid testing for HIV, HCV, and syphilis, as well as COVID-19 and flu vaccines and blood pressure checks. Each visit takes roughly 20 minutes, and while individuals wait for their test results, a registered nurse provides education on harm reduction, HIV PrEP and PEP, and doxy PEP for sexually transmitted infections. Additionally, community health representatives at the mobile clinic help people check-in and provide education on the available services. The community health representatives have also expressed interest in learning how to provide rapid point-of-care HIV tests to expand capacity.

Incentives are used to drive testing efforts, and word about R2R has spread throughout the community. One community member receiving services remarked, “I haven’t been tested for HIV or syphilis in 21 years until today, but now I know my status.” Another observed, “It’s a lot easier to come here and get tested than at the clinic.” R2R soon will be adding penicillin injections for syphilis treatment, with the ability to treat individuals immediately following a rapid syphilis test, and multi-site gonorrhea and chlamydia testing with the addition of a portable restroom that will support self-sample collection.

The EHE Initiative

The activities discussed in this post are just three examples of the many innovative approaches being taken by partners working in each of the 57 prioritized jurisdictions to scale up four science-based strategies: diagnose, treat, prevent, and respond. The jurisdictions receive additional funding and technical assistance from CDC’s Division of HIV Prevention, HRSA’s Health Center Program and Ryan White HIV/AIDS Program to implement locally tailored plans to reduce new HIV transmissions by 90% by 2030. NIH and IHS also support complementary activities. OIDP supports these efforts through community engagement and information sharing by its EHE and Engagement Teams, as well as by sharing information on HIV.gov and managing the AHEAD Dashboard. To learn more about the EHE initiative, visit HIV.gov’s EHE sectionRead more about OIDP’s Engagement Team.

Apply Now: Opportunities to Support Research and Career Development

CHIPTS is excited to share funding opportunity announcements for the 2024 HIV Global Public Health Travel Fellowship program and the 2025 Mentored Pilot Grant Program. These opportunities are designed to prompt new science and support research among emerging investigators. We encourage applications expressing interest in HIV prevention, substance use, and/or mental health services. Learn more about each program below.

2025 Mentored Pilot Grant Program

The pilot grant for emerging and new investigators (ranging from doctoral students to assistant professors) provides mentorship from engaged and committed faculty mentors/sponsors on a well-defined research project that can last up to 12 months. The successful completion of the proposed mentored research project is expected to enhance emerging and new investigators’ potential to develop into productive, independent research scientists. Applicants are encouraged to submit proposals of innovative and transformative domestic and international social, behavioral, policy, and combination prevention pilot studies that will produce data and experiences that will support future funded grants and career development.

Application Deadline: Monday, July 29, 2024 by 5pm PT

Funds Deadline: Saturday, November 1, 2025

Visit the CHIPTS Mentored Pilot Grant Program page to learn more about submission requirements. We also invite you to review the full 2025 CHIPTS Mentored Pilot Grant – Call for Applications.

Questions about the program or requests for assistance in identifying a CHIPTS faculty mentor can be directed to:

The application packet should be submitted via email to Damilola Jolayemi: OJolayemi@mednet.ucla.edu.

2024 HIV Global Public Health Travel Fellowship

The fellowship program is designed to support researchers to develop research opportunities either in a new global setting or to reinvigorate global health collaborations and research that have not been active for at least 2 years. Applicants who have a strong commitment and interest in doing research addressing the intersection of HIV/AIDS treatment and prevention and mental health and/or substance use co-morbidities in global settings are highly encouraged to apply. The purpose is to provide researchers with opportunities to observe and learn new research approaches and methods, experience implementation science in a different cultural context, and stimulate new research activities in a global setting.

Application Deadline: Applications are accepted and reviewed on a rolling basis until Friday, August 30, 2024.

Funds Deadline: All travel funded by the Fellowship must be completed by Thursday, October 31, 2024.

Visit the CHIPTS HIV Global Public Health Travel Fellowship page to learn more about submission requirements. We also invite you to review the full CHIPTS HIV Global Public Health Travel Fellowship 2024 – Call for Applications.

The application packet should be submitted via email to Pamina Gorbach, DrPH, MHS, CHIPTS HIV Global Director, at pgorbach@ucla.edu.

Please contact Dr. Gorbach if you have any questions or need assistance identifying global host/contact.